Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 9Completed 7Active not recruiting 4Withdrawn 3Unknown 2Terminated 2Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1NIH 1INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Genitourinary 3

Conditions

Urinary Bladder Neoplasms 3Urinary Bladder Neck Obstruction 1Urinary Bladder Calculi 1Nephrolithiasis 1Kidney Diseases 1Carcinoma, Transitional Cell 1

Interventions

Cyclophosphamide 129Cisplatin 119Radiotherapy 115pembrolizumab 111Carboplatin 97Paclitaxel 96Gemcitabine 96Magnetic Resonance Spectroscopy 80Nivolumab 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Biopsy 53Doxorubicin 52fludarabine 51Drug Therapy 45durvalumab 44Cytarabine 44Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Surveys and Questionnaires 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × Cystoscopy × Clear all
NCT05564416 2025-10-21

Testing Anti-Cancer Drugs Erdafitinib With or Without Atezolizumab in Patients With Localized Bladder Cancer Not Able to Receive Cisplatin Chemotherapy, NERA Trial

National Cancer Institute (NCI)

Phase 2 Withdrawn
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT06422312 2025-04-04

A Study Comparing a Disposable Flexible Cystoscope With Reusable Scopes in Adult Patients.

Guangzhou Red Pine Medical Instrument Co., Ltd.

Phase NA Withdrawn
Genitourinary

Urinary Bladder Calculi, Urinary Bladder Neck Obstruction, Urinary Bladder Neoplasms, Kidney Diseases, Nephrolithiasis

NCT05260788 2022-04-14

Mapping 3D Bladder

University Health Network, Toronto

Withdrawn
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡